Karkala: Youth molests, attempts to kill girl in photo studio; caught by locals

Bengaluru, Feb 19: Karnataka Chief Minister B.S. Yediyurappa thanked his Kerala counterpart Pinarayi Vijayan for initiating action against those dumping bio-medical and bio-wastes in Karnataka's districts from neighboring state Kerala.

In a statement, he said, "First I would like to thank Kerala Chief Minister Pinnarayi Vijayan for his prompt reaction and response to initiate legal action against the dumpers of bio-medical and bio-waste in our districts neighboring Kerala."

The Karnataka Chief Minister has taken a serious note of the reports in a section of media on alleged dumping of bio-medical waste and bio-waste by people from Kerala in bordering Mysuru, Kodagu and Chamarajnagar districts.

"I have directed deputy commissioners of concerned districts, environment department, and pollution control board to take stock of the situation and check surreptitious activities of individuals and agencies from Kerala who are indulging in this illegal activity. I have also directed the officials to prevent the use of this bio-medical waste by Jaggery units as fuel," Yediyurappa said.

He assured that soon this activity will be checked and ended.

Mangaluru, Jan 14: Mangaluru city police commissionerate his notified traffic diversions on NH 73 in view of massive protest at Adyra Kannur in the city against CAA, NPR and NRC on January 15. It also has issued guidelines for the public, protesters and organisers of the protest.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.